DK1121109T3 - Tofaset sammensætning med tramadol - Google Patents

Tofaset sammensætning med tramadol

Info

Publication number
DK1121109T3
DK1121109T3 DK99953856T DK99953856T DK1121109T3 DK 1121109 T3 DK1121109 T3 DK 1121109T3 DK 99953856 T DK99953856 T DK 99953856T DK 99953856 T DK99953856 T DK 99953856T DK 1121109 T3 DK1121109 T3 DK 1121109T3
Authority
DK
Denmark
Prior art keywords
active substance
weight
tramadol
phase composition
release rate
Prior art date
Application number
DK99953856T
Other languages
English (en)
Inventor
Udo Hahn
Walter Wimmer
Bianca Broegmann
Christof Spitzley
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of DK1121109T3 publication Critical patent/DK1121109T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK99953856T 1998-10-15 1999-10-15 Tofaset sammensætning med tramadol DK1121109T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE29818454U DE29818454U1 (de) 1998-10-15 1998-10-15 Opioid-Analgetikum

Publications (1)

Publication Number Publication Date
DK1121109T3 true DK1121109T3 (da) 2006-10-02

Family

ID=8063985

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99953856T DK1121109T3 (da) 1998-10-15 1999-10-15 Tofaset sammensætning med tramadol

Country Status (10)

Country Link
EP (1) EP1121109B8 (da)
JP (1) JP5414956B2 (da)
AT (1) ATE327742T1 (da)
AU (1) AU1039400A (da)
CY (1) CY1105168T1 (da)
DE (2) DE29818454U1 (da)
DK (1) DK1121109T3 (da)
ES (1) ES2267301T3 (da)
PT (1) PT1121109E (da)
WO (1) WO2000021520A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2452871C (en) 2001-07-06 2011-10-04 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
ATE376832T1 (de) * 2001-07-06 2007-11-15 Penwest Pharmaceuticals Co Verzögert freisetzende formulierungen von oxymorphon
DK2425824T5 (da) 2002-04-05 2018-02-12 Mundipharma As Farmaceutisk præparat indeholdende oxycodon og naloxon
JP2006328053A (ja) * 2005-04-26 2006-12-07 Takeda Chem Ind Ltd モルヒネ含有医薬
CN101410103B (zh) * 2006-03-30 2013-04-10 日本脏器制药株式会社 固体药物制剂
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
AU2011236548A1 (en) * 2010-04-07 2012-11-01 Lupin Limited Controlled release pharmaceutical compositions of tapentadol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109460A (en) * 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5645858A (en) * 1994-10-06 1997-07-08 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US6159501A (en) * 1996-03-08 2000-12-12 Nycomed Danmark A/S Modified release multiple-units dosage composition for release of opioid compounds
DE19710008A1 (de) * 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung

Also Published As

Publication number Publication date
ATE327742T1 (de) 2006-06-15
JP5414956B2 (ja) 2014-02-12
JP2002527384A (ja) 2002-08-27
DE29818454U1 (de) 1999-01-14
AU1039400A (en) 2000-05-01
EP1121109B8 (de) 2006-07-19
WO2000021520A3 (de) 2000-08-03
DE59913493D1 (de) 2006-07-06
EP1121109A2 (de) 2001-08-08
PT1121109E (pt) 2006-09-29
WO2000021520A2 (de) 2000-04-20
ES2267301T3 (es) 2007-03-01
EP1121109B1 (de) 2006-05-31
CY1105168T1 (el) 2010-03-03

Similar Documents

Publication Publication Date Title
WO2003072025A3 (en) Modified release formulations of at least one form of tramadol
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
WO2001085257A3 (en) Opioid antagonist compositions and dosage forms
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
AU7407387A (en) Controlled release dihydrocodeine composition
NO20022264D0 (no) Farmasöytisk blanding inneholdende tolterodin, samt anvendelse derav
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
BG103795A (en) Pharmaceutical compositions with appetite suppressing activity
BR9908545A (pt) Derivado de piperidina, processo para a preparação do mesmo, composto, processo para a preparação do mesmo, e, composição farmacêutica
HRP20010243B1 (en) Compositions containing diphosphonic acids
AP1849A (en) Dosage regimen and pharmaceutical composition for emergency contraception
SG162605A1 (en) Pharmaceutical compositions
DK1121109T3 (da) Tofaset sammensætning med tramadol
CA2415154A1 (en) Modified release formulations of selective serotonin re-uptake inhibitors
BR0207297A (pt) Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
WO2001051055A3 (en) Pharmaceutical compositions containing steroidal structures and uses thereof
EP1300160A4 (en) METHOD FOR STABILIZING A PREPARATION
WO2002017877A3 (en) Controlled release pharmaceutical pellet compositions for reducing side effects of drugs
YU20050411A (sh) Komopzicije oksikodona sa kontrolisanim oslobadanjem
WO2002081462A8 (en) Aminoflavone compounds, compositions, and methods of use thereof
BR0010449A (pt) 14beta-h-esteróis, composições farmacêuticas que compreendem os mesmos e uso destes derivados para a preparação de medicamentos reguladores da meiose
BR0215680A (pt) Composição farmacêutica oral estável
AP2003002905A0 (en) Sertraline salts and sustained-release dosage forms of sertraline.
EP1769799A3 (en) Pharmaceutical compositions containing steroidal structures and uses thereof
YU20050409A (sh) Kompozicije oksikodona sa kontrolisanim oslobađanjem